Načítá se...
Prasugrel in critically ill patients
While prasugrel is indicated for the treatment of myocardial infarction, its effects in the most severely affected patients requiring intensive care is unknown, so that we measured the antiplatelet effects and sparse pharmacokinetics of prasugrel in critically ill patients. Twenty-three patients adm...
Uloženo v:
| Vydáno v: | Thromb Haemost |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Schattauer GmbH
2017
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6292180/ https://ncbi.nlm.nih.gov/pubmed/28692105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1160/TH17-03-0154 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|